Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients
David M. Routman, Ryan K. Funk, Bradley J. Stish, Lance A. Mynderse, Torrence M. Wilson, Robert McLaren, W. Scott Harmsen, Kristin Mara, Christopher L. Deufel, Keith M. Furutani, Michael G. Haddock, Thomas M. Pisansky, C. Richard Choo, Brian J. Davis
Dive into the research topics of 'Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients'. Together they form a unique fingerprint.